Comparison of mouse and human cytochrome P450 mediated-drug metabolising activities in hepatic and extrahepatic microsomes

References

• Bieche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, de Waziers I. 2007. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics. 17(9):731–742.
   PubMed Web of Science ®Google Scholar
• Bogaards JJ, Bertrand M, Jackson P, Oudshoorn MJ, Weaver RJ, van Bladeren PJ, Walther B. 2000. Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica. 30(12):1131–1152.
   PubMed Web of Science ®Google Scholar
• Born SL, Caudill D, Fliter KL, Purdon MP. 2002. Identification of the cytochromes P450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation. Drug Metab Dispos. 30(5):483–487.
   PubMed Web of Science ®Google Scholar
• Emoto C, Yamazaki H, Yamasaki S, Shimada N, Nakajima M, Yokoi T. 2000. Characterization of cytochrome P450 enzymes involved in drug oxidations in mouse intestinal microsomes. Xenobiotica. 30(10):943–953.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. 2021. A history of the roles of cytochrome P450 enzymes in the toxicity of drugs. Toxicol Res. 37(1):1–23.
   PubMed Web of Science ®Google Scholar
• Lasker JM, Wester MR, Aramsombatdee E, Raucy JL. 1998. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations. Arch Biochem Biophys. 353(1):16–28.
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis G, de Kanter R. 2006. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine. Drug Metab Dispos. 34(6):1047–1054.
   PubMed Web of Science ®Google Scholar
• Mimura M, Yamazaki H, Sugahara C, Hiroi T, Funae Y, Shimada T. 1994. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes. Biochem Pharmacol. 47(11):1957–1963.
   PubMed Web of Science ®Google Scholar
• Murayama N, Kaneko N, Horiuchi K, Ohyama K, Shimizu M, Ito K, Yamazaki H. 2009. Cytochrome P450-dependent drug oxidation activity of liver microsomes from microminipigs, a possible new animal model for humans in non-clinical studies. Drug Metab Pharmacokinet. 24(4):404–408.
   PubMed Web of Science ®Google Scholar
• Murayama N, Yamazaki H. 2021. Metabolic activation and deactivation of dietary-derived coumarin mediated by cytochrome P450 enzymes in rat and human liver preparations. J Toxicol Sci. 46(8):371–378.
   PubMed Web of Science ®Google Scholar
• Nelson DR. 2006. Cytochrome P450 nomenclature, 2004. Methods Mol Biol. 320:1–10.
   PubMedGoogle Scholar
• Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. 2004. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics. 14(1):1–18.
   PubMedGoogle Scholar
• Pearce R, Greenway D, Parkinson A. 1992. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Arch Biochem Biophys. 298(1):211–225.
   PubMed Web of Science ®Google Scholar
• Renaud HJ, Cui JY, Khan M, Klaassen CD. 2011. Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice. Toxicol Sci. 124(2):261–277.
   PubMed Web of Science ®Google Scholar
• Sakai N, Saito K, Kim HS, Kazusaka A, Ishizuka M, Funae Y, Fujita S. 2005. Importance of CYP2D3 in polymorphism of diazepam p-hydroxylation in rats. Drug Metab Dispos. 33(11):1657–1660.
   PubMed Web of Science ®Google Scholar
• Sharma V, McNeill JH. 2009. To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol. 157(6):907–921.
   PubMed Web of Science ®Google Scholar
• Shimada T, Mimura M, Inoue K, Nakamura S, Oda H, Ohmori S, Yamazaki H. 1997. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans. Arch Toxicol. 71(6):401–408.
   PubMed Web of Science ®Google Scholar
• Tracy TS, Marra C, Wrighton SA, Gonzalez FJ, Korzekwa KR. 1996. Studies of flurbiprofen 4'-hydroxylation. Additional evidence suggesting the sole involvement of cytochrome P450 2C9. Biochem Pharmacol. 52(8):1305–1309.
   PubMed Web of Science ®Google Scholar
• Turpeinen M, Ghiciuc C, Opritoui M, Tursas L, Pelkonen O, Pasanen M. 2007. Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: a comparative study in vitro. Xenobiotica. 37(12):1367–1377.
   PubMed Web of Science ®Google Scholar
• Uehara S, Murayama N, Yamazaki H, Suemizu H. 2019. Regioselective hydroxylation of an antiarrhythmic drug, propafenone, mediated by rat liver cytochrome P450 2D2 differs from that catalyzed by human P450 2D6. Xenobiotica. 49(11):1323–1331.
   PubMed Web of Science ®Google Scholar
• Uehara S, Yoneda N, Higuchi Y, Yamazaki H, Suemizu H. 2022. Cytochrome P450-dependent drug oxidation activities and their expression levels in liver microsomes of chimeric TK-NOG mice with humanized livers. Drug Metab Pharmacokinet. 44: 100454.
   Web of Science ®Google Scholar
• von Weymarn LB, Murphy SE. 2003. CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6. Xenobiotica. 33(1):73–81.
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Mimura M, Sugahara C, Shimada T. 1994. Catalytic roles of rat and human cytochrome P450 2A enzymes in testosterone 7 alpha- and coumarin 7-hydroxylations. Biochem Pharmacol. 48(7):1524–1527.
   PubMed Web of Science ®Google Scholar
• Yasumori T, Nagata K, Yang SK, Chen LS, Murayama N, Yamazoe Y, Kato R. 1993. Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner. Pharmacogenetics. 3(6):291–301.
   PubMedGoogle Scholar
• Zanger UM, Schwab M. 2013. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 138(1):103–141.
   PubMed Web of Science ®Google Scholar
• Zhuo X, Gu J, Zhang QY, Spink DC, Kaminsky LS, Ding X. 1999. Biotransformation of coumarin by rodent and human cytochromes P-450: metabolic basis of tissue-selective toxicity in olfactory mucosa of rats and mice. J Pharmacol Exp Ther. 288(2):463–471.
   PubMed Web of Science ®Google Scholar